Simplify Life with Omnipod® 5
No multiple daily injections or finger prick testing‡. Omnipod 5 proactively helps to correct highs and protect from lows1,2 –simplify your diabetes management.
How it works
Every five minutes the glucose Sensor reports glucose levels to the Pod. SmartAdjust™ technology within the Pod automatically adjusts your insulin.
- When glucose levels are dropping, insulin delivery automatically decreases or pauses.
- When glucose levels are rising, insulin delivery automatically increases.
Get to know the Omnipod 5 System
The Pod
Tubeless, wearable, and waterproof†, each Pod sits comfortably on the body for up to 3 days (72 hours), automatically adjusting insulin delivery thanks to its built-in SmartAdjust™ technology.
The Controller
Take charge of your diabetes with the handheld Omnipod 5 Controller, which connects seamlessly to your Pod via Bluetooth® for discreet, wireless control.
The Sensor
Your choice of compatible Sensor continuously sends glucose values to the Pod, giving you real-time readings§ without the hassle of finger pricks‡. The Pod and Sensor need to be in ‘line of sight’ to stay in Automated Mode. Placing them on the same side of the body allows for best communication between the devices.
3 simple parts. One continuous loop of communication.
When paired with a compatible Continuous Glucose Monitor (CGM) sensor, Omnipod 5 can give constant and automatic insulin delivery to keep you in range, day and night2-3. Omnipod 5 is compatible with Dexcom G6, Dexcom G7, and FreeStyle Libre 2 Plus Sensor..
Here’s what our Podders have to say about Omnipod®:
Omnipod 5 has allowed me to get a good night sleep. That's the first time I can say that in a long time.
Alvin
Podder since 2017
It helps me feel like a normal kid, just with a little bit of help.
Romey T.
Sponsored Omnipod® User
& Podder since 2019
I don’t have to spend as much time thinking about diabetes.
Clare F.
Podder® since 2013
Get started with one of these options
Pod Experience Kit
The Pod Experience Kit* contains a real-size, real weight demo Pod*, without the insulin. It’s designed to give you an idea of what it feels like to wear a Pod, and get a sense of how discreet it can be.
Join a Live Demo
Register for a free virtual live demo to see Omnipod 5 in action. The 60 minute session includes an overview of Pod Therapy and a walk-through of everything from activating a Pod to delivering an insulin bolus.
Speak to an Omnipod Specialist
Still have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat.
Want to know more about Omnipod?
To learn more about Omnipod 5, check out our library of resources.
‡Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
†The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof.
1. The Omnipod 5 System was named 2023 Patient Choice Award Winner for preferred pump in the United States; Source: Seagrove Patient Perspectives Survey Report (413 Total Responses, 260 T1D, 153 T2D 245 pumpers, 98 MDI, 70 non-MDI). Seagrove Partners, LLC Patient Perspectives Report, December 2023. Insulet data on file.
2. Brown S. et al. Diabetes Care (2021). Study in 240 people with T1D aged 6 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Average time with low blood glucose in adults/adolescents and children, standard therapy vs 3-month Omnipod 5: 2.9% vs. 1.3%; 2.2% vs. 1.8%. Study funded by Insulet.
3. Sherr JL, et al. Diabetes Care (2022). Study in 80 people with T1D aged 2 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 39.4% vs. 29.5%. Average time with low blood glucose in very young children, standard therapy vs 3-month Omnipod 5: 3.41% vs. 2.13%. Study funded by Insulet.
Intended Purpose as per Instructions for Use for The Omnipod 5 Automated Insulin Delivery System :
The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older requiring insulin.
The Omnipod 5 System is intended to operate as an automated insulin delivery system when used with compatible Continuous Glucose Monitors (CGM).
When in Automated Mode, the Omnipod 5 System is designed to assist people with type 1 diabetes in achieving glycaemic targets set by their healthcare providers. It is intended to modulate (increase, decrease or suspend) insulin delivery to operate within predefined threshold values using current and predicted sensor glucose values to maintain blood glucose at variable target glucose levels, thereby reducing glucose variability. This reduction in variability is intended to lead to a reduction in the frequency, severity, and duration of both hyperglycaemia and hypoglycaemia.
The Omnipod 5 System can also operate in a Manual Mode that delivers insulin at set or manually adjusted rates.
The Omnipod 5 System is intended for single patient use.
The Omnipod 5 System is indicated for use with U-100 rapid acting insulin.
Warning: DO NOT start to use the Omnipod® 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over delivery or under-delivery of insulin, which could lead to hypoglycaemia or hyperglycaemia.